Chemokine system: New inflammatory markers on the horizon

European Journal of Inflammation

Volumn 8, Issue 1, 2010, Pages 1-6

  Galliera, Emanuela ^a   Locati, M ^a   Mantovani, A ^a   Corsi, M M ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

Author keywords

Chemokine; Chemokine receptors; Human diseases biomarkers

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CXCL16 CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STROMAL CELL DERIVED FACTOR 1;

ALLERGIC DISEASE; AUTOIMMUNE DISEASE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CELL MIGRATION; COST; DISEASE ACTIVITY; GRAFT REJECTION; HOMEOSTASIS; HUMAN; IMMUNE MEDIATED INJURY; INFLAMMATION; NEOPLASM; PROGNOSIS; REVIEW; VASCULAR DISEASE;

EID: 77952685198     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1000800101     Document Type: Review

References (20)

1. Rollins BJ. Chemokines. Blood 1997; 90:909-928.
2. Locati M, Murphy PM. Chemokines and chemokine receptors. Biology and clinical relevance in inflammation and AIDS. Annu Rev Med 1999; 50: 425-440.
3. Aukrust P, Yndestad A, Smith C, Ueland T, Gullestad L, Damas JK. Chemokines in cardiovascular risk prediction. Thromb Haemost 2007; 97:748-754
4. Sun Y, Chang Z, Zhang S. Increased serum cxcl16 level is a marker for acute coronary syndromes. Arch Med Res 2008; 39:332-337 (Pubitemid 351221149)
5. Dahl CP, Husberg C, Gullestad L, et al. Increased production of cxcl16 in experimental and clinical heart failure. A possible role in extracellular matrix remodeling. Circ Heart Fail 2009; 2:624-632.
6. Gutwein P, Abdel-Bakky MS, Doberstein K, et al. Cxcl16 and oxldl are induced in the onset of diabetic nephropathy. J Cell Mol Med 2009; Epub ahead of print.
7. Gutwein P, Abdel-Bakky MS, Schramme A, et al. Cxcl16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein. Am J Pathol 2009; 174:2061-2072
8. Yi GW, Zeng QT. Circulating cxcl16 is related to the severity of coronary artery stenosis. Arch Med Res 2008; 39:531-535 (Pubitemid 351726359)
9. Klatte T, Seligson DB, Leppert JT, et al. The chemokine receptor cxcr3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma. J Urol 2008; 179:61-66 (Pubitemid 350216740)
10. Yoshitake N, Fukui H, Yamagishi H, et al. Expression of sdf-1 alpha and nuclear cxcr4 predicts lymph node metastasis in colorectal cancer. Br J Cancer 2008; 98:1682-1689 (Pubitemid 351684689)
11. Gutwein P, Schramme A, Sinke N, et al. Tumoural cxcl16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. Eur J Cancer 2009; 45:478-489
12. Bienvenu J, Monneret G, Fabien N, Revillard JP. The clinical usefulness of the measurement of cytokines. Clin Chem Lab Med 2000; 38:267-285
13. Mire-Sluis AR. Cytokines. From technology to therapeutics. Trends Biotechnol 1999; 17:319-325
14. House RV. Cytokine measurement techniques for assessing hypersensitivity. Toxicology 2001; 158:51-58.
15. Mahajan SD, Schwartz SA, Nair MP. Immunological assays for chemokine detection in in vitro culture of ens cells. Biol Proced Online 2003; 5:90-102.
16. Hashida N, Ohguro N, Nakai K, Kobashi-Hashida M, Hashimoto S, Matsushima K, Tano Y. Microarray analysis of cytokine and chemokine gene expression after prednisolone treatment in murine experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 2005; 46:4224-4234 (Pubitemid 44264626)
17. Giavedoni LD. Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using luminex technology. J Immunol Methods 2005; 301:89-101.
18. Dupuy AM, Lehmann S, Cristol JP. Protein biochip systems for the clinical laboratory. Clin Chem Lab Med 2005; 43:1291-1302
19. Molloy RM, Mc Connell RI, Lamont JV, FitzGerald SP. Automation of biochip array technology for quality results. Clin Chem Lab Med 2005; 43:1303-1313
20. Fitzgerald SP, Lamont JV, McConnell RI, Benchikh el O. Development of a high-throughput automated analyzer using biochip array technology. Clin Chem 2005; 51:1165-1176